Path analysis of biomarkers for cognitive decline in early Parkinson’s disease

Clinical and biochemical diversity of Parkinson’s disease (PD) and numerous demographic, clinical, and pathological measures influencing cognitive function and its decline in PD create problems with the determination of effects of individual measures on cognition in PD. This is particularly the case...

Descripción completa

Detalles Bibliográficos
Autores principales: Gramotnev, Dmitri K., Gramotnev, Galina, Gramotnev, Alexandra, Summers, Mathew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106174/
https://www.ncbi.nlm.nih.gov/pubmed/35560326
http://dx.doi.org/10.1371/journal.pone.0268379

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106174/
https://www.ncbi.nlm.nih.gov/pubmed/35560326
http://dx.doi.org/10.1371/journal.pone.0268379

Ejemplares similares